ARRU, Giannina
 Distribuzione geografica
Continente #
NA - Nord America 3.001
EU - Europa 1.851
AS - Asia 1.204
SA - Sud America 14
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.091
Nazione #
US - Stati Uniti d'America 2.980
UA - Ucraina 851
CN - Cina 801
SG - Singapore 335
DE - Germania 308
IT - Italia 211
SE - Svezia 169
FI - Finlandia 140
GB - Regno Unito 48
FR - Francia 39
BE - Belgio 24
CA - Canada 19
KR - Corea 18
CZ - Repubblica Ceca 17
TR - Turchia 17
IN - India 16
AU - Australia 11
BR - Brasile 10
NL - Olanda 8
EU - Europa 7
ES - Italia 5
IR - Iran 5
RO - Romania 4
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
LT - Lituania 3
AL - Albania 2
AT - Austria 2
CL - Cile 2
HK - Hong Kong 2
ID - Indonesia 2
JP - Giappone 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
GE - Georgia 1
IE - Irlanda 1
LV - Lettonia 1
ME - Montenegro 1
MX - Messico 1
OM - Oman 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 6.091
Città #
Chandler 694
Jacksonville 534
Princeton 285
Singapore 247
Nanjing 237
Dearborn 228
Wilmington 126
Nanchang 90
Ann Arbor 77
Beijing 64
Ashburn 57
Boardman 53
Hebei 51
Shenyang 49
Sassari 48
New York 43
Changsha 42
Tianjin 40
Jiaxing 37
Santa Clara 35
Woodbridge 27
Jinan 26
Brussels 24
Kunming 22
Norwalk 22
Ningbo 21
Andover 20
Munich 19
San Francisco 19
Seoul 18
Zhengzhou 17
San Mateo 16
Hangzhou 15
Brno 14
Mountain View 13
Toronto 13
Falls Church 11
Los Angeles 11
Shanghai 11
Guangzhou 10
Helsinki 10
Monmouth Junction 10
Haikou 8
Izmir 8
London 7
Rome 7
Augusta 6
Hefei 6
Leawood 6
Taizhou 6
Sydney 5
Bologna 4
Changchun 4
Dallas 4
Frankfurt am Main 4
Melbourne 4
Milan 4
Ardabil 3
Auburn Hills 3
Bellante 3
Brescia 3
Edinburgh 3
Espoo 3
Florence 3
Hørsholm 3
Lanzhou 3
Macomer 3
Madrid 3
Nuoro 3
Oristano 3
Ottawa 3
Paris 3
Shenzhen 3
Syracuse 3
Tallinn 3
Vélizy 3
Amsterdam 2
Bucharest 2
Budapest 2
Casavatore 2
Chisinau 2
Civitavecchia 2
Clearwater 2
Corciano 2
Delhi 2
Fuzhou 2
Hanover 2
Houston 2
Hyderabad 2
Lonato 2
Markham 2
Modena 2
Montebelluna 2
Olomouc 2
Shaoxing 2
St Louis 2
Tirana 2
Turin 2
Zurich 2
Alghero 1
Totale 3.593
Nome #
Rilevazione differenziale di MSRV e sincitina nel RNA e DNA di pazienti con sclerosi multipla 133
Novel reliable real-time PCR for differential detection of MSRVenv and Syncytin-1 in RNA and DNA from patients with multiple sclerosis 93
JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab 89
Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden 88
Characterisation of an HIV-1 strain with preferential replication in adherent cells 76
Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis 73
A possible prognostic role for MSRV in multiple sclerosis. 71
Serum uric acid and multiple sclerosis 70
Optic neuritis and conversion to definite MS: comparison between MS-associated retrovirus and other prognostic markers 68
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 67
Clinical expression of multiple sclerosis and the polymorphisms of the Chitotriosidase 65
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 63
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 63
Unequivocal linkage to multiple sclerosis of the MS-associated retrovirus in distinct European populations 62
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1 61
Extracellular release of the HERV-W Multiple sclerosis-associated retrovirus (MSRV) and its regulation by cytokines and HIV 61
Clinical expression of multiple sclerosis and the polymorphisms of the Chitotriosidase. 60
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients 59
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients 59
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis 58
Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis 57
Multiple sclerosis-associated retrovirus in patients with optic neuritis: prevalence and outccome in a Swedish cohort 57
Multiple sclerosis: peripheral mononuclear cells inhibit Plasmodium falciparum growth and are activated by parasite antigens 56
Inflammatory biomarkers in blood of patients with acute brain ischemia 56
Anti-Inflammatory Liver X Receptors and Related Molecules in Multiple Sclerosis Patients from Sardinia and Sweden 56
Multiple sclerosis-associated retrovirus and MS prognosis: an observational study 55
In vitro modulation of dendritic cells and lymphocytes by glatiramer acetate. Implications for multiple sclerosis treatment 55
Expression of human endogenous retroviruses in multiple sclerosis brain and glial cell cultures 55
VAPB ER-Aggregates, A Possible New Biomarker in ALS Pathology 55
Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease 54
Multiple sclerosis and chitotriosidase: a novel association 54
Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis 53
Glatiramer acetate inhibits dendritic cells capability to stimulate lymphocytes proliferation 53
A family based linkage analysis of HLA and 5-HTTLPR gene polymorphisms in Sardinian children with autism spectrum disorder 52
Multiple sclerosis and hygiene hypothesis: reduced Toll-like receptor 9 expression in MS in response to P. falciparum 52
Il retrovirus HERV-W associato alla sclerosi multipla (MSRV) viene rilasciato da linfociti di soggetti portatori ed è sensibile a citochine e HIV 52
In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: Implications for MS pathogenesis 51
Intrathecal chitotriosidase and the outcome of multiple sclerosis 51
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease? 51
Constitutive Expression of human endogenous retroviruses in normal and multiple sclerosis brains and glial cell cultures 51
Circulating Multiple Sclerosis (MS)-associated retrovirus (MSRV) correlates with MS, is increased in vitro by proinflammatory and inhibited by interferon beta both in vitro and in vivo 51
Chitotriosidase in patients with acute ischemic stroke 50
Absence of correlation between expression of the multiple sclerosis-associated retrovirus (MSRV)/ERV-W in MS patients and controls and presence of human herpesvirus-6 50
Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease? 49
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 49
Quantitative and qualitative RT-PCR detection of the multiple sclerosis (MS)-associated retrovirus in populations of different ethnicity 48
Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6 48
Chitotriosidase and Alzheimer's disease 48
Chitotriosidase in multiple sclerosis 47
NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients 47
In vitro release and modulation of Multiple Sclerosis-Associated HERV-W Retrovirus by peripheral blood mononuclear cells from virus-positive subjects. 47
Multiple sclerosis and anti-Plasmodium falciparum innate immune response 46
Multiple sclerosis prognosis. A possible role for MSRV 46
Anti-inflammatory liver x receptors and related molecules in multiple sclerosis patients from Sardinia and Sweden 46
Effetti Contrastanti da Interferon-γ dei due principali corecettori per HIV e vantaggio selettivo per il legame di HIV-M tropico a cellule aderenti 46
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 46
Il-2 and mycobacterial lipoarabinomannan as targets of immune responses in multiple sclerosis patients 46
Multiple sclerosis-associated retrovirus in patients with optic neuritis: prevalence and outcome in a Swedish cohort 45
Characterization of an HIV type 1 strain with preferential replication in adherent cells 45
Multiple sclerosis in Sardinia: Reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 by pDC in response to herpes simplex virus type 1 45
Viral infection in multiple sclerosis is associated with low proportion of plasmacytoid dendritic cells and low production of the protective cytokines IL-6 and IL-10 45
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients 45
Fucosyl-oligosaccharides decrease mononuclear cells in vitro activation, particularly in multiple sclerosis 44
Constitutive Expression of human endogenous retroviruses in Normal and multiple sclerosis brains and glial cell cultures 44
Acute brain ischemia and inflammation. An outcome study 44
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 44
MSRV/HERV-W and Sardinian Multiple Sclerosis 44
Possible selection of a Sardinian variant of the Multiple Sclerosis-Associated Retrovirus. 44
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. 44
Seroprevalence of Hepatitis B Virus Markers in a Cohort Of Sardinian Patients With Multiple Sclerosis. 44
MSRV as a prognostic factor in Sardinian patients: 10-year follow-up 43
MS-associated retrovirus in optic neuritis and non-inflammatory controls: a prevalence study in a Swedish population 42
Copolymer-1 modulation of dendritic cells-mediated lymphocytes proliferation is restricted to multiple sclerosis 42
RE: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672]. 42
Multiple sclerosis: dendritic cells and lymphocytes are modulated by Glatiramer acetatein vitro 41
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects. 41
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 41
Human endogenous retroviruses in glial cell cultures and brain tissues. Further evidences for their role in multiple sclerosis 41
Multiple sclerosis (MS) associated retrovirus (MSRV) in patients with monosymptomatic optic neuritis: comparison to other prognostic markers in Swedish patients 40
Selezione di una variante Sarda del retrovirus associato alla Sclerosi multipla (MSRV) e sua modulazione e rilascio in vitro da PBMC di soggetti virus positivi 40
Multiple sclerosis-associated retrovirus in patients with optic neuritis: prevalence and outccome in a Swedish cohort 40
Detection of MSRV in MS patients from different European populations and in relation to clinical activity 39
The MSRV/HERV-W env protein is expressed in brain lesion of MS patients and not in normal-apparing control brains 39
Deficiency of BDCA2+ and BDCA4+ cells in multiple sclerosis. 38
Association between lipoprotein levels and humoral reactivity to mycobacterium avium subsp. Paratuberculosis in multiple sclerosis, type 1 diabetes mellitus and rheumatoid arthritis 38
Presenza del MSRV (multiple sclerosis-associated retrovirus) in pazienti MS e controlli di etnia sarda: possibile ruolo patogenetico e caratterizzazione molecolare 38
Seasonal fluctuation of multiple sclerosis births in Sardinia 38
MSRV (Multiple sclerosis(MS)-associated retrovirus) circolante correla in vivo con la malattia; il virus è stimolato da citochine proinfiammatorie in vitro ed è inibito da interferon beta sia in vitro che in vivo 37
La Proteina env di HERV-W/MSRV è espresso nelle lesioni cerebrali di pazienti SM ma non nei controlli sani 36
Multiple sclerosis. (MS)-associated HERV-W retrovirus in the CSF and MS course. Results from a 3-years follow-up 35
Multiple sclerosis-associated retrovirus and IFN therapy: a correlation study 35
Human Endogenous Retroviral Particles In MS Samples From Different European Ms Populations and in Relation To Clinical Activity 35
Multiple Sclerosis and HERV-W/MSRV: A multicentric Study 34
Genes, environment, and susceptibility to multiple sclerosis 33
Espressione di MSRV (Multiple sclerosis-associated retrovirus)/HERV-W in pazienti affetti da MS e controlli e confronto con quella di HHV-6 (Human Herpesvirus-6) 33
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study. 33
Expression and regulation by cytokines of Multiple Sclerosis (MS)-associated retrovirus (MSRV), in vitro and in vivo 32
Multiple sclerosis, malaria and the “hygiene hypothesis” in Sardinia 32
Copolymer-1 modulation of dendritic cells-mediated lymphocytes proliferation is restricted to multiple sclerosis 32
Multiple sclerosis (MS)-associated retrovirus in plasma and cerebrospinal fluid of optic neuritis patients: a clinico-radiological study. 32
Totale 5.024
Categoria #
all - tutte 33.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020929 0 0 0 0 136 210 231 16 150 39 144 3
2020/20211.050 137 3 172 5 140 38 141 6 150 162 75 21
2021/2022615 78 4 3 4 5 7 33 50 56 30 71 274
2022/20231.351 146 77 24 219 137 220 1 161 263 7 60 36
2023/2024423 72 34 14 9 68 32 37 21 2 27 34 73
2024/2025533 39 18 239 118 119 0 0 0 0 0 0 0
Totale 6.198